These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 16506984)
1. Heterogeneity of cancer risk due to stochastic effects. Heidenreich WF Risk Anal; 2005 Dec; 25(6):1589-94. PubMed ID: 16506984 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of cancer risk due to stochastic effects: emphasis on radiation-induced effects. Heidenreich WF Radiat Environ Biophys; 2006 May; 45(1):33-7. PubMed ID: 16596426 [TBL] [Abstract][Full Text] [Related]
3. A numerical solution to the nonhomogeneous two-stage MVK model of cancer. Crump KS; Subramaniam RP; Van Landingham CB Risk Anal; 2005 Aug; 25(4):921-6. PubMed ID: 16268939 [TBL] [Abstract][Full Text] [Related]
4. Symmetry, identifiability, and prediction uncertainties in multistage clonal expansion (MSCE) models of carcinogenesis. Cox LA; Huber WA Risk Anal; 2007 Dec; 27(6):1441-53. PubMed ID: 18093045 [TBL] [Abstract][Full Text] [Related]
5. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study. Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969 [TBL] [Abstract][Full Text] [Related]
6. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study. Clemente C; Elba S; Buongiorno G; Guerra V; D'Attoma B; Orlando A; Russo F Liver Int; 2007 Aug; 27(6):791-7. PubMed ID: 17617122 [TBL] [Abstract][Full Text] [Related]
7. Analysis of solid cancer mortality in the techa river cohort using the two-step clonal expansion model. Eidemüller M; Ostroumova E; Krestinina L; Akleyev A; Jacob P Radiat Res; 2008 Feb; 169(2):138-48. PubMed ID: 18220471 [TBL] [Abstract][Full Text] [Related]
8. Hormesis without cell killing. Cox LA Risk Anal; 2009 Mar; 29(3):393-400. PubMed ID: 18793280 [TBL] [Abstract][Full Text] [Related]
9. Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. Inoue M; Noda M; Kurahashi N; Iwasaki M; Sasazuki S; Iso H; Tsugane S; Eur J Cancer Prev; 2009 Jun; 18(3):240-7. PubMed ID: 19491612 [TBL] [Abstract][Full Text] [Related]
10. The age distribution of human adult cancer and an initiation-manifestation model for carcinogenesis. Ohtaki M; Fujita S; Hayakawa N; Kurihara M; Munaka M Jpn J Clin Oncol; 1985 Apr; 15 Suppl 1():325-43. PubMed ID: 4009994 [TBL] [Abstract][Full Text] [Related]
11. Estimation and prediction system for multi-state disease process: application to analysis of organized screening regime. Chang CM; Lin WC; Kuo HS; Yen MF; Chen TH J Eval Clin Pract; 2007 Dec; 13(6):867-81. PubMed ID: 18070257 [TBL] [Abstract][Full Text] [Related]
12. Comparing regression methods for the two-stage clonal expansion model of carcinogenesis. Kaiser JC; Heidenreich WF Stat Med; 2004 Nov; 23(21):3333-50. PubMed ID: 15490436 [TBL] [Abstract][Full Text] [Related]
13. Extinction risk depends strongly on factors contributing to stochasticity. Melbourne BA; Hastings A Nature; 2008 Jul; 454(7200):100-3. PubMed ID: 18596809 [TBL] [Abstract][Full Text] [Related]
14. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer. Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987 [TBL] [Abstract][Full Text] [Related]
15. Lung cancer in chrysotile asbestos workers: analyses based on the two-stage clonal expansion model. Richardson DB Cancer Causes Control; 2009 Aug; 20(6):917-23. PubMed ID: 19184474 [TBL] [Abstract][Full Text] [Related]
16. Donation frequency, iron loss, and risk of cancer among blood donors. Edgren G; Reilly M; Hjalgrim H; Tran TN; Rostgaard K; Adami J; Titlestad K; Shanwell A; Melbye M; Nyrén O J Natl Cancer Inst; 2008 Apr; 100(8):572-9. PubMed ID: 18398098 [TBL] [Abstract][Full Text] [Related]
17. Mortality in co-morbidity (II)--excess death rates derived from a follow-up study on 10,025 subjects divided into 4 groups with or without depression and diabetes mellitus. Milano AF; Singer RB J Insur Med; 2007; 39(3):160-6. PubMed ID: 18251374 [TBL] [Abstract][Full Text] [Related]
18. [Model for estimation of cardiovascular risk in Norway]. Selmer R; Lindman AS; Tverdal A; Pedersen JI; Njølstad I; Veierød MB Tidsskr Nor Laegeforen; 2008 Jan; 128(3):286-90. PubMed ID: 18264151 [TBL] [Abstract][Full Text] [Related]
19. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study. Whitfield MD; Gillett M; Holmes M; Ogden E Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425 [TBL] [Abstract][Full Text] [Related]
20. Update of potency factors for asbestos-related lung cancer and mesothelioma. Berman DW; Crump KS Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]